Respiratory Syncytial Virus, Human
"Respiratory Syncytial Virus, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.
| Descriptor ID |
D018113
|
| MeSH Number(s) |
B04.820.455.600.670.600.750.730
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus, Human".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus, Human".
This graph shows the total number of publications written about "Respiratory Syncytial Virus, Human" by people in this website by year, and whether "Respiratory Syncytial Virus, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus, Human" by people in Profiles.
-
Tran PT, Nduaguba SO, Wang Y, Diaby V, Finelli L, Choi Y, Winterstein AG. Economic Burden of Medically Attended Respiratory Syncytial Virus Infections Among Privately Insured Children Under 5?Years of Age in the USA. Influenza Other Respir Viruses. 2024 Jul; 18(7):e13347.
-
Quandelacy TM, Adams LE, Munoz J, Santiago GA, Kada S, Johansson MA, Alvarado LI, Rivera-Amill V, Paz-Bailey G. Reduced spread of influenza and other respiratory viral infections during the COVID-19 pandemic in southern Puerto Rico. PLoS One. 2022; 17(4):e0266095.
-
Mebratu YA, Tesfaigzi Y. Is IL-1? a Target for Reducing Hospitalization of Infants Infected with Respiratory Syncytial Virus? Am J Respir Cell Mol Biol. 2022 03; 66(3):248-249.
-
Tiwari PM, Vanover D, Lindsay KE, Bawage SS, Kirschman JL, Bhosle S, Lifland AW, Zurla C, Santangelo PJ. Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection. Nat Commun. 2018 10 01; 9(1):3999.
-
Richard CA, Rincheval V, Lassoued S, Fix J, Cardone C, Esneau C, Nekhai S, Galloux M, Rameix-Welti MA, Sizun C, El?ou?t JF. RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcription. PLoS Pathog. 2018 03; 14(3):e1006920.
-
Yorita KL, Holman RC, Steiner CA, Effler PV, Miyamura J, Forbes S, Anderson LJ, Balaraman V. Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii. Pediatr Infect Dis J. 2007 Dec; 26(12):1081-8.
-
Molinari Such M, Garc?a I, Garc?a L, Puig G, Pedraza L, Mar?n J, Valc?rcel M. Respiratory syncytial virus-related bronchiolitis in Puerto Rico. P R Health Sci J. 2005 Jun; 24(2):137-40.